Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC25A14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GTF2IP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTIF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MSL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLOD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL2BP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP35 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506098 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MGAT4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SENP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLUL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALNT7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2R5E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNGTT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506990 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUSP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP47 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on